ConductScience.org, home

Paper31379844

Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han.

Deng Z and 18 others. Front Immunol, 2019. Cited by 20 papers, by iCite.

Cite this record

ConductScience Library. Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han. Papers, record 31379844. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31379844

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han.
PubMed
Journal
Front Immunol
PubMed
Year
2019
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
20
iCite
Relative citation ratio, by iCite
0.84
iCite
Revised in PubMed
2025-05-30
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Deng ZZhihui
2Zhao JJun
3Cai SSiqi
4Qi YYing
5Yu QQiong
6Martin MPMaureen P
7Gao XXiaojiang
8Chen RRui
9Zhuo JJiacai
10Zhen JJianxin
11Zhang MMingjie
12Zhang GGuobin
13He LLiumei
14Zou HHongyan
15Lu LLiang
16Zhu WWeigang
17Hong WWenxu
18Carrington MMary
19Norman PJPaul J

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
LeukemiaMajor topic
Adult
Asian People
Child
Female
Genotype
Histocompatibility Antigens Class I
Humans
Male
Receptors, KIR

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
HHSN261200800001CCCR NIH HHSUnited StatesPubMedPubMed
HHSN261200800001ENCI NIH HHSUnited StatesPubMedPubMed
U01 AI090905NIAID NIH HHSUnited StatesU01AI090905PubMed and NIHNIH RePORTER
U19 NS095774NINDS NIH HHSUnited StatesU19NS095774PubMed and NIHNIH RePORTER

Download CSV of grants

References73

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112493005The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.Immunol Rev2002https://conductscience.org/library/papers/12493005PubMed
215470487Identification of natural killer cell receptor phenotypes associated with leukemia.Leukemia2004https://conductscience.org/library/papers/15470487PubMed
31547670Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry.Cytometry1992https://conductscience.org/library/papers/1547670PubMed
415604012CD107a as a functional marker for the identification of natural killer cell activity.J Immunol Methods2004https://conductscience.org/library/papers/15604012PubMed
515744340CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.Leukemia2005https://conductscience.org/library/papers/15744340PubMed
615755898Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells.Blood2005https://conductscience.org/library/papers/15755898PubMed
715896204Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.Tissue Antigens2005https://conductscience.org/library/papers/15896204PubMed
816533882Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.J Exp Med2006https://conductscience.org/library/papers/16533882PubMed
916761016Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions.Leukemia2006https://conductscience.org/library/papers/16761016PubMed
1016824023The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense.Annu Rev Genomics Hum Genet2006https://conductscience.org/library/papers/16824023PubMed
1117285553[Polymorphism of killer cell immunoglobulin-like receptor 2DL3 gene in Zhejiang Han population].Zhonghua Yi Xue Yi Chuan Xue Za Zhi2007https://conductscience.org/library/papers/17285553PubMed
1217694054Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans.Nat Genet2007https://conductscience.org/library/papers/17694054PubMed
1317900288HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.Tissue Antigens2007https://conductscience.org/library/papers/17900288PubMed
1417947671Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.J Immunol2007https://conductscience.org/library/papers/17947671PubMed
1518638659Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies.Hum Immunol2008https://conductscience.org/library/papers/18638659PubMed
1618941190Estimation of the size of the alloreactive NK cell repertoire: studies in individuals homozygous for the group A KIR haplotype.J Immunol2008https://conductscience.org/library/papers/18941190PubMed
1719342631NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat model.J Immunol2009https://conductscience.org/library/papers/19342631PubMed
1819383914Expansion of highly cytotoxic human natural killer cells for cancer cell therapy.Cancer Res2009https://conductscience.org/library/papers/19383914PubMed
1919450876Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.Leuk Res2010https://conductscience.org/library/papers/19450876PubMed
2019493232Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.Tissue Antigens2009https://conductscience.org/library/papers/19493232PubMed

See all 73 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.

PMIDTitleJournalYearIn PapersSource
42712389Contrasting relapse rate associated with the absence of HLA-A3/A11 in T cell-replete haploidentical transplantation.Front Immunol2026https://conductscience.org/library/papers/42712389PubMed
41717357KIR AA individuals possess strong inhibitory KIR alleles alongside HLA ligands that are protective against leukemia in the Chinese population.Front Genet2025https://conductscience.org/library/papers/41717357PubMed
36699439Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian Cohort.Indian J Hematol Blood Transfus2023https://conductscience.org/library/papers/36699439PubMed
36689727Large case-control study indicates no association of KIR genotype and risk of developing acute myeloid leukemia.Blood Adv2023https://conductscience.org/library/papers/36689727PubMed
35561968Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human Health.J Allergy Clin Immunol Pract2022https://conductscience.org/library/papers/35561968PubMed
35192601Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1.PLoS Comput Biol2022https://conductscience.org/library/papers/35192601PubMed
33995358High-Resolution Analysis Identifies High Frequency of KIR-A Haplotypes and Inhibitory Interactions of KIR With HLA Class I in Zhejiang Han.Front Immunol2021https://conductscience.org/library/papers/33995358PubMed
33986753Natural Killer Cell Subpopulations and Inhibitory Receptor Dynamics in Myelodysplastic Syndromes and Acute Myeloid Leukemia.Front Immunol2021https://conductscience.org/library/papers/33986753PubMed
33616658Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians.Mol Biol Evol2021https://conductscience.org/library/papers/33616658PubMed
33257819Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients.Genes Immun2020https://conductscience.org/library/papers/33257819PubMed
32420357KIR3DL1 and HLA-Bw4 Interaction Showed a Favorable Role in Patients with Myelodysplastic Syndromes in Chinese Southern Han.Biomed Res Int2020https://conductscience.org/library/papers/32420357PubMed
32269692Killer cell immunoglobulin-like receptor gene cluster predisposes to susceptibility to B-cell acute lymphoblastic leukemia in Chinese children.Int J Clin Exp Pathol2020https://conductscience.org/library/papers/32269692PubMed

Download CSV of cited by

Genes19

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-B3106PubTator's text mininghttps://conductscience.org/library/genes/3106NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
HLA-E3133PubTator's text mininghttps://conductscience.org/library/genes/3133NCBI Gene
IL153600PubTator's text mininghttps://conductscience.org/library/genes/3600NCBI Gene
KIR2DL13802PubTator's text mininghttps://conductscience.org/library/genes/3802NCBI Gene
KIR2DL33804PubTator's text mininghttps://conductscience.org/library/genes/3804NCBI Gene
KIR2DL43805PubTator's text mininghttps://conductscience.org/library/genes/3805NCBI Gene
KIR2DP1554300PubTator's text mininghttps://conductscience.org/library/genes/554300NCBI Gene
KIR2DS43809PubTator's text mininghttps://conductscience.org/library/genes/3809NCBI Gene
KIR3DL13811PubTator's text mininghttps://conductscience.org/library/genes/3811NCBI Gene
KIR3DL23812PubTator's text mininghttps://conductscience.org/library/genes/3812NCBI Gene
KIR3DL3115653PubTator's text mininghttps://conductscience.org/library/genes/115653NCBI Gene
KIR3DP1548594PubTator's text mininghttps://conductscience.org/library/genes/548594NCBI Gene
KLRC13821PubTator's text mininghttps://conductscience.org/library/genes/3821NCBI Gene
KLRD13824PubTator's text mininghttps://conductscience.org/library/genes/3824NCBI Gene
LAMP13916PubTator's text mininghttps://conductscience.org/library/genes/3916NCBI Gene
NCAM14684PubTator's text mininghttps://conductscience.org/library/genes/4684NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/31379844

GET https://conductscience.org/api/papers/v1/31379844/references?page=2